Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:olopatadine
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01GX09
|
| gptkbp:availableOn |
over-the-counter
prescription |
| gptkbp:form |
gptkb:government_agency
eye drops |
| https://www.w3.org/2000/01/rdf-schema#label |
Pataday
|
| gptkbp:legalStatus |
OTC (US)
Rx-only (some countries) |
| gptkbp:manufacturer |
gptkb:Alcon
|
| gptkbp:mechanismOfAction |
antihistamine
mast cell stabilizer |
| gptkbp:powers |
0.2%
0.1% |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
ophthalmic
|
| gptkbp:sideEffect |
headache
blurred vision eye irritation |
| gptkbp:usedFor |
allergic conjunctivitis
|
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|